Your browser doesn't support javascript.
loading
Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian, Deepak; Shaikh, Furqan; van den Bos, Cor; Somers, Gino R; Astigarraga, Itziar; Jubran, Rima; Degar, Barbara; Carret, Anne-Sophie; Mandel, Karen; Belletrutti, Mark; Dix, David; Visser, Johannes; Abuhadra, Nour; Chang, Tiffany; Rollins, Barret; Whitlock, James; Weitzman, Sheila; Abla, Oussama.
Affiliation
  • Chellapandian D; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Shaikh F; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • van den Bos C; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands.
  • Somers GR; Division of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Astigarraga I; Servicio de Pediatria, Bio Cruces Health Research Institute, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain.
  • Jubran R; Departamento de Pediatria, Universidad del Pais Vasco UPV/EHU, Vizcaya, Spain.
  • Degar B; Children's Hospital of Los Angeles, Los Angeles, California.
  • Carret AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mandel K; Division of Hematology-Oncology, Department of Pediatrics, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
  • Belletrutti M; Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
  • Dix D; Department of Pediatrics, University of Alberta, Stollery Children's Hospital, Edmonton, Alberta, Canada.
  • Visser J; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Abuhadra N; Leicester Children's Hospital, Leicester, UK.
  • Chang T; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Rollins B; Keck School of Medicine of the University of Southern California, Los Angeles, California.
  • Whitlock J; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.
  • Weitzman S; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Abla O; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Pediatr Blood Cancer ; 62(12): 2162-6, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26179251
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Database: MEDLINE Main subject: Bone Diseases / Histiocytosis, Langerhans-Cell / Neurodegenerative Diseases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Database: MEDLINE Main subject: Bone Diseases / Histiocytosis, Langerhans-Cell / Neurodegenerative Diseases Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Year: 2015 Document type: Article